Healthcare - Biotechnology - NASDAQ - GB
$ 11.2
-3.78 %
$ 8.15 B
Market Cap
1.95
P/E
Price Target
Average
49.00%
Revenue Forecast
Estimate
68.96%
EBIT
Estimate
--4.45%
Net Income
Estimate
--47.84%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Roivant Sciences Ltd.
Wall Street analysts predict an average 1-year price target for ROIV of $16.7 , with forecasts ranging from a low of $12.5 to a high of $20 .
ROIV Lowest Price Target
Wall Street Target
12.5 USD
11.61%
ROIV Average Price Target
Wall Street Target
16.7 USD
49.00%
ROIV Highest Price Target
Wall Street Target
20 USD
78.57%
REVENUE FORECAST
Revenue Forecast Chart ROIV
EBIT FORECAST
EBIT Forecast Chart ROIV
NET INCOME FORECAST
Net Income Chart ROIV